About NYBC Ventures

New York Blood Center created NYBC Ventures to accelerate innovation in blood-related fields and cellular therapies and technology. The fund was established by New York Blood Center with a $50 million investment and a mission to improve patients' lives by advancing therapeutics, enabling platforms and technologies, and driving collaborations to expand NYBC's impact.

Investment Details

Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
Finance, VR/AR
Investor Type
Venture Capital

Investment Focus

Focus Areas
Finance VR/AR
Investment Stages
Early Stage Venture, Late Stage Venture, Later Stage, Seed